Allogeneic CD19/BCMA CAR-T

CD19/BCMA CAR-T cell therapy · The Children's Hospital of Zhejiang University School of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic CD19/BCMA CAR-T, covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease [EARLY_Phase 1]